Skip to main content

A Phase 2 Multi-Center, Open Label Study to Assess the Safety, Efficacy and Pharmacodynamics of IMG-7289 in Patients with Essential Thrombocythemia

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Imago BioSciences

Start Date

October 2, 2020

End Date

December 28, 2023
 

Administered By

Duke Cancer Institute

Awarded By

Imago BioSciences

Start Date

October 2, 2020

End Date

December 28, 2023